Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shai Shimony, Uri Rozovski, Neta Sudry, Moshe Yeshurun, Dafna Yahav, Pia Raanani & Ofir Wolach. (2020) Early detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment. Leukemia & Lymphoma 61:11, pages 2708-2713.
Read now
Read now
Stefan Becker, Sini Korpelainen, Miika Arvonen, Sari Hämäläinen, Esa Jantunen, Marika Lappalainen, Kari Pulkki, Pekka Riikonen & Auni Juutilainen. (2019) MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia. Leukemia & Lymphoma 60:12, pages 3036-3043.
Read now
Read now
Marika Lappalainen, Sari Hämäläinen, Auni Juutilainen, Irma Koivula, Kari Pulkki & Esa Jantunen. (2017) Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients. Scandinavian Journal of Clinical and Laboratory Investigation 77:2, pages 130-134.
Read now
Read now
Omar Abdel-Rahman, Hesham ElHalawani & Shaimaa Essam-Eldin. (2016) S-1-based regimens and the risk of leucopenic complications; a Meta-analysis with comparison to other fluoropyrimidines and non fluoropyrimidines. Expert Opinion on Drug Safety 15:4, pages 437-448.
Read now
Read now
Auni Juutilainen, Sari Hämäläinen, Kari Pulkki, Taru Kuittinen, Tapio Nousiainen, Esa Jantunen & Irma Koivula. (2011) Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis. Leukemia & Lymphoma 52:12, pages 2349-2355.
Read now
Read now
Sari Hämäläinen, Auni Juutilainen, Taru Kuittinen, Tapio Nousiainen, Irma Matinlauri, Kari Pulkki, Irma Koivula & Esa Jantunen. (2010) Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leukemia & Lymphoma 51:6, pages 1040-1046.
Read now
Read now
Auni Juutilainen, Sari Hämäläinen, Irma Matinlauri, Taru Kuittinen, Tapio Nousiainen, Kari Pulkki, Irma Koivula & Esa Jantunen. (2010) Serial plasma lactate measurements in haematological patients with neutropenic fever. Scandinavian Journal of Infectious Diseases 42:2, pages 102-108.
Read now
Read now
Sari Hämäläinen, T. Kuittinen, I. Matinlauri, T. Nousiainen, I. Koivula & E. Jantunen. (2009) Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcome. Scandinavian Journal of Infectious Diseases 41:1, pages 14-20.
Read now
Read now
Andrew Artz & David Pitrak. (2008) Separating correlation from prediction: C-reactive protein and infectious complications after chemotherapy for acute myeloid leukemia. Leukemia & Lymphoma 49:3, pages 381-382.
Read now
Read now
Articles from other publishers (45)
Sandro Trova, Fei Lin, Santosh Lomada, Matthew Fenton, Bhavini Chauhan, Alexandra Adams, Avani Puri, Alessandro Di Maio, Thomas Wieland, Daniel Sewell, Kirstin Dick, Daniel Wiseman, Deepti P. Wilks, Margaret Goodall, Mark T. Drayson, Farhat L. Khanim & Christopher M. Bunce. (2023) Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. PLOS ONE 18:7, pages e0288162.
Crossref
Crossref
Sabine Ehrlich, Karsten Spiekermann, Jan Hendrik Grothe & Jannik Stemler. (2023) Infektionen bei Patient*innen mit Akuter Myeloischer Leukämie. DMW - Deutsche Medizinische Wochenschrift 148:08, pages 467-473.
Crossref
Crossref
Huan Tao, Fang Hua, Yingying Chen & Yongqian Jia. (2022) Metagenomic Next-Generation Sequencing (mNGS) for the Timely Diagnosis of Carbapenem-Resistant Klebsiella pneumoniae in Leukemia Patients. Case Reports in Infectious Diseases 2022, pages 1-5.
Crossref
Crossref
Lu Chen, Chao Li, Hao Bai, Lixian Li & Wanyi Chen. (2022) Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib. Frontiers in Pharmacology 13.
Crossref
Crossref
Fernanda Rodrigues Mendes, Wellington Fernandes da Silva, Raphael da Costa Bandeira de Melo, Douglas Rafaele Almeida Silveira, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha & Eduardo Magalhaes Rego. (2021) Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting. Annals of Hematology 101:1, pages 147-154.
Crossref
Crossref
Ji Wan Kang, Youngjoo Kim, Yoonsung Lee, Kyungjae Myung, Yun Hak Kim & Chang‐Kyu Oh. (2020) AML poor prognosis factor, TPD52, is associated with the maintenance of haematopoietic stem cells through regulation of cell proliferation. Journal of Cellular Biochemistry 122:3-4, pages 403-412.
Crossref
Crossref
Kundan Mishra, Suman Kumar, Sandeep Ninawe, Rajat Bahl, Ashok Meshram, Kanwaljeet Singh, Aditya Jandial, Kamal Kant Sahu, Rajeev Sandal, Sanjeev Khera, Uday Yanamandra, Harshit Khurana, Rajiv Kumar, Rajan Kapoor, Sanjeevan Sharma, Jasjit Singh, Satyaranjan Das, Ankur Ahuja, Venkateshan Somasundaram & Tathagat Chaterjee. (2021) The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings. Therapeutic Advances in Infectious Disease 8, pages 204993612110365.
Crossref
Crossref
Marika Lappalainen, Sari Hämäläinen, Tuomo Romppanen, Kari Pulkki, Marja Pyörälä, Irma Koivula, Esa Jantunen & Auni Juutilainen. (2020) Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C‐reactive protein, and blood culture findings. European Journal of Haematology 105:6, pages 731-740.
Crossref
Crossref
Erin E. Watson, Jessica E. Metcalfe, Matthew R. Kreher, Walter G. Maxymiw, Michael Glogauer & Aaron D. Schimmer. (2020) Screening for Dental Infections Achieves 6-Fold Reduction in Dental Emergencies During Induction Chemotherapy for Acute Myeloid Leukemia. JCO Oncology Practice 16:11, pages e1397-e1405.
Crossref
Crossref
Marwan M. Azar, David C. Gaston, Camille N. Kotton & Maricar F. Malinis. (2020) Emerging Microbiology Diagnostics for Transplant Infections: On the Cusp of a Paradigm Shift. Transplantation 104:7, pages 1358-1384.
Crossref
Crossref
Jennifer L Guida, Tim A Ahles, Daniel Belsky, Judith Campisi, Harvey Jay Cohen, James DeGregori, Rebecca Fuldner, Luigi Ferrucci, Lisa Gallicchio, Leonid Gavrilov, Natalia Gavrilova, Paige A Green, Chamelli Jhappan, Ronald Kohanski, Kevin Krull, Jeanne Mandelblatt, Kirsten K Ness, Ann O’Mara, Nathan Price, Jennifer Schrack, Stephanie Studenski, Olga Theou, Russell P Tracy & Arti Hurria. (2019) Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors. JNCI: Journal of the National Cancer Institute 111:12, pages 1245-1254.
Crossref
Crossref
Daniel A. Pollyea, Martin S. Tallman, Stéphane de Botton, Hagop M. Kantarjian, Robert Collins, Anthony S. Stein, Mark G. Frattini, Qiang Xu, Alessandra Tosolini, Wendy L. See, Kyle J. MacBeth, Samuel V. Agresta, Eyal C. Attar, Courtney D. DiNardo & Eytan M. Stein. (2019) Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia. Leukemia 33:11, pages 2575-2584.
Crossref
Crossref
Carina Intke, Sini Korpelainen, Sari Hämäläinen, Matti Vänskä, Irma Koivula, Esa Jantunen, Kari Pulkki & Auni Juutilainen. (2018) Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients. European Journal of Haematology 101:5, pages 691-698.
Crossref
Crossref
Ni-hong Pang, Qian Liu, Xiang-ran Lu, Su-fen Yang, Dong-dong Lin & Guo-xin Hu. (2018) Determination and pharmacokinetic study of Enasidenib in rat plasma by UPLC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis 157, pages 165-170.
Crossref
Crossref
Kazuhiro Horiba, Jun-ichi Kawada, Yusuke Okuno, Nobuyuki Tetsuka, Takako Suzuki, Shotaro Ando, Yasuko Kamiya, Yuka Torii, Tetsuya Yagi, Yoshiyuki Takahashi & Yoshinori Ito. (2018) Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing. Scientific Reports 8:1.
Crossref
Crossref
Eytan M Stein. (2018) Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia. Future Oncology 14:1, pages 23-40.
Crossref
Crossref
Marika Lappalainen, Jenna Jokkala, Auni Juutilainen, Sari Hämäläinen, Irma Koivula, Esa Jantunen, Kati Hanhineva & Kari Pulkki. (2018) Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics. Disease Markers 2018, pages 1-16.
Crossref
Crossref
Imrana A. Malik, Marylou Cardenas-Turanzas, Susan Gaeta, Gautum Borthakur, Kristen Price, Jorge Cortes & Joseph L. Nates. (2017) Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals. Clinical Lymphoma Myeloma and Leukemia 17:12, pages e27-e32.
Crossref
Crossref
Eytan M. SteinCourtney D. DiNardoDaniel A. PollyeaAmir T. FathiGail J. RobozJessica K. AltmanRichard M. StoneDaniel J. DeAngeloRoss L. LevineIan W. FlinnHagop M. KantarjianRobert CollinsManish R. PatelArthur E. FrankelAnthony SteinMikkael A. SekeresRonan T. SwordsBruno C. MedeirosChristophe WillekensParesh VyasAlessandra Tosolini, Qiang Xu, Robert D. Knight, Katharine E. Yen, Sam Agresta, Stephane de BottonMartin S. Tallman. (2017) Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood 130:6, pages 722-731.
Crossref
Crossref
Beata Krawczyk, Anna Śledzińska, Agnieszka Piekarska, Andrzej Hellmann & Józef Kur. (2017) Recurrent bowel-blood translocations of Escherichia coli with the unique virulence characteristics over three-year period in the patient with acute myeloid leukaemia – case report. Journal of Applied Genetics 58:3, pages 415-418.
Crossref
Crossref
J. Klastersky, J. de Naurois, K. Rolston, B. Rapoport, G. Maschmeyer, M. Aapro & J. Herrstedt. (2016) Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Annals of Oncology 27, pages v111-v118.
Crossref
Crossref
J M Schuurhuis, L F R Span, M A Stokman, A J van Winkelhoff, A Vissink & F K L Spijkervet. (2016) Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy. British Journal of Cancer 114:9, pages 972-978.
Crossref
Crossref
P. Gyarmati, C. Kjellander, C. Aust, Y. Song, L. Öhrmalm & C. G. Giske. (2016) Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia. Scientific Reports 6:1.
Crossref
Crossref
Mojtaba Ghadiany, Hossein Rahimi, Hamid Rezvani, Afshin Mohammad Alizadeh, Nasim Zamani, Mahshid Mehdizadeh & Mohammad Foratyazdi. (2016) Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. Asia-Pacific Journal of Clinical Oncology 12:1, pages e11-e15.
Crossref
Crossref
Seong Hyun Jeong, Dae Young Kim, Jun Ho Jang, Yeung-Chul Mun, Chul Won Choi, Sung-Hyun Kim, Jin Seok Kim & Joon Seong Park. (2015) Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study. Annals of Hematology 95:2, pages 337-344.
Crossref
Crossref
Daniel P. Mould, Alison E. McGonagle, Daniel H. Wiseman, Emma L. Williams & Allan M. Jordan. (2015) Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date. Medicinal Research Reviews 35:3, pages 586-618.
Crossref
Crossref
U Schnetzke, B Spies-Weisshart, O Yomade, M Fischer, T Rachow, K Schrenk, A Glaser, M von Lilienfeld-Toal, A Hochhaus & S Scholl. (2014) Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia. Genes & Immunity 16:1, pages 83-88.
Crossref
Crossref
Olaf Penack, Carolin Becker, Dieter Buchheidt, Maximilian Christopeit, Michael Kiehl, Marie von Lilienfeld-Toal, Marcus Hentrich, Marc Reinwald, Hans Salwender, Enrico Schalk, Martin Schmidt-Hieber, Thomas Weber & Helmut Ostermann. (2014) Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Annals of Hematology 93:7, pages 1083-1095.
Crossref
Crossref
Marion E. G. Brunck & Lars K. Nielsen. (2014) Concise Review: Next-Generation Cell Therapies to Prevent Infections in Neutropenic Patients. Stem Cells Translational Medicine 3:4, pages 541-548.
Crossref
Crossref
Justyna Dzietczenia. (2013) Profilaktyka neutropenii u pacjentów w wieku podeszłym. Acta Haematologica Polonica 44:2, pages 124-129.
Crossref
Crossref
Matti Vänskä, Irma Koivula, Esa Jantunen, Sari Hämäläinen, Anna-Kaisa Purhonen, Kari Pulkki & Auni Juutilainen. (2012) IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients. Cytokine 60:3, pages 787-792.
Crossref
Crossref
Christian Kjellander, Magnus Björkholm, Honar Cherif, Mats Kalin & Christian G. Giske. (2012) Hematological: Low all‐cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single‐center study. European Journal of Haematology 88:5, pages 422-430.
Crossref
Crossref
Lillian Sung, Allen Buxton, Alan Gamis, William G. Woods & Todd A. Alonzo. (2012) Life-threatening and Fatal Infections in Children With Acute Myeloid Leukemia. Journal of Pediatric Hematology/Oncology 34:1, pages e30-e35.
Crossref
Crossref
Auni Juutilainen, Sari Hämäläinen, Juuso Niemenpää, Taru Kuittinen, Kari Pulkki, Irma Koivula, Leo Niskanen & Esa Jantunen. (2011) Serum cortisol and inflammatory response in neutropenic fever. Annals of Hematology 90:12, pages 1467-1475.
Crossref
Crossref
Kanakadurga Singer, Perla Subbaiah, Raymond Hutchinson, Folafoluwa Odetola & Thomas P. Shanley. (2011) Clinical course of sepsis in children with acute leukemia admitted to the pediatric intensive care unit*. Pediatric Critical Care Medicine 12:6, pages 649-654.
Crossref
Crossref
Anthony R. Mato, Alicia K. Morgans & Selina M. Luger. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
97
114
.
Sharon C-A Chen & Dimitrios P Kontoyiannis. (2010) New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Current Opinion in Infectious Diseases 23:6, pages 567-577.
Crossref
Crossref
Irma Matinlauri, Auni Juutilainen, Sari Hämäläinen, Irma Koivula, Taru Kuittinen & Esa Jantunen. (2010) Fibrinogen and antithrombin in hematological patients with neutropenic fever. Open Medicine 5:4, pages 520-526.
Crossref
Crossref
J. de Naurois, I. Novitzky-Basso, M.J. Gill, F. Marti Marti, M.H. Cullen & F. Roila. (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annals of Oncology 21, pages v252-v256.
Crossref
Crossref
Matthew D. Seftel. (2010) Controversies in the management of fever in the neutropenic cancer patient. Transfusion and Apheresis Science 42:2, pages 151-156.
Crossref
Crossref
Karin U. Sorenmo, Lisa P. Harwood, Lesley G. King & Kenneth J. Drobatz. (2010) Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy. Journal of the American Veterinary Medical Association 236:6, pages 650-656.
Crossref
Crossref
Sari Hämäläinen, Auni Juutilainen, Irma Matinlauri, Taru Kuittinen, Esko Ruokonen, Irma Koivula & Esa Jantunen. (2009) Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein. European Journal of Haematology 83:3, pages 251-257.
Crossref
Crossref
F. Marti Marti, M.H. Cullen & F. Roila. (2009) Management of febrile neutropenia: ESMO Clinical Recommendations. Annals of Oncology 20, pages iv166-iv169.
Crossref
Crossref
Stefania Varani, Marta Stanzani, Michela Paolucci, Fraia Melchionda, Gastone Castellani, Lorenzo Nardi, Maria Paola Landini, Michele Baccarani, Andrea Pession & Vittorio Sambri. (2009) Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. Journal of Infection 58:5, pages 346-351.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:9.
Crossref
Crossref